Stauffer, W.; Bobardt, M.; Ure, D.; Foster, R.; Gallay, P.
The Cyclophilin Inhibitor Rencofilstat Decreases HCV-Induced Hepatocellular Carcinoma Independently of Its Antiviral Activity. Viruses 2023, 15, 2099.
https://doi.org/10.3390/v15102099
AMA Style
Stauffer W, Bobardt M, Ure D, Foster R, Gallay P.
The Cyclophilin Inhibitor Rencofilstat Decreases HCV-Induced Hepatocellular Carcinoma Independently of Its Antiviral Activity. Viruses. 2023; 15(10):2099.
https://doi.org/10.3390/v15102099
Chicago/Turabian Style
Stauffer, Winston, Michael Bobardt, Daren Ure, Robert Foster, and Philippe Gallay.
2023. "The Cyclophilin Inhibitor Rencofilstat Decreases HCV-Induced Hepatocellular Carcinoma Independently of Its Antiviral Activity" Viruses 15, no. 10: 2099.
https://doi.org/10.3390/v15102099
APA Style
Stauffer, W., Bobardt, M., Ure, D., Foster, R., & Gallay, P.
(2023). The Cyclophilin Inhibitor Rencofilstat Decreases HCV-Induced Hepatocellular Carcinoma Independently of Its Antiviral Activity. Viruses, 15(10), 2099.
https://doi.org/10.3390/v15102099